Pharma innovation: how evolutionary economics is shaping the future of pharma R&D

•Evolutionism provides a framework to understand business model shifts, linking challenges to future advantages.•Digital competencies, new therapeutic modalities and COVID-19 lessons will shape future R&D.•Technology-investigating and asset-integrating pharma companies as emerging business model...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drug discovery today 2024-12, Vol.29 (12), p.104222, Article 104222
1. Verfasser:	Schuhmacher, Alexander
Format:	Artikel
Sprache:	eng
Schlagworte:	artificial intelligence business model Drug Industry - economics Drug Industry - trends evolutionary economics Humans pharma R&D R&D productivity Research - economics Research - trends therapeutic modalities
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!